Corvus Pharmaceuticals Stock (CRVS)
Track Corvus Pharmaceuticals stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
CRVS
Corvus Pharmaceuticals
healthcare
$14.72
▲ +9.11 (+167.16%) past year
Market Cap
$1.19B
P/E Ratio
—
1Y Return
+167.16%
EPS (TTM)
-$0.62
Read the latest TheStreet Pro articles mentioning Corvus Pharmaceuticals, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning CRVS yet.
Daily Diary Mentions
0 mentionsNo diary mentions for CRVS yet.